APO Research

APO RESEARCH · REPORT

Hemostatic Forceps

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

Product & engineering

Understand the product.

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.

Selected research

Industry Research

Hemostatic Forceps Industry Research Report 2026

Market perspective

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.

Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.

Read the full market overview

North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.

In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.

Report Scope

This report quantifies the global Hemostatic Forceps market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Hemostatic Forceps Market by Company

Medline

B. Braun

CareFusion

Asa Dental

Sklar

Scanlan International

Shanghai Medical Instruments

Lawton

Hu-Friedy

Xinhua Surgical

Towne Brothers

Teleflex Medical

Delacroix Chevalier

YDM

M A Corporation

MedGyn Products

Inami

Ted Pella

Medicon eG

J & J Instruments

American Diagnostic

Hemostatic Forceps Segment by Type

Halstead Mosquito Hemostatic Forceps

Kelly and Crile Hemostatic Forceps

Rochester-Carmalt Hemostatic Forceps

Hemostatic Forceps Segment by Application

Surgical

Dissection

Dental

Laparoscopic

Others

Hemostatic Forceps Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Forceps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Forceps and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Forceps.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Hemostatic Forceps manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Hemostatic Forceps by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Hemostatic Forceps in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hemostatic Forceps Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Hemostatic Forceps Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Hemostatic Forceps Sales Market Share by Manufacturers (2021-2026) Table 8. Global Hemostatic Forceps Revenue of Manufacturers (2021-2026) Table 9. Global Hemostatic Forceps Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Hemostatic Forceps Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global Hemostatic Forceps Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Hemostatic Forceps, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Hemostatic Forceps, Product Type & Application Table 14. Global Hemostatic Forceps Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Hemostatic Forceps by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Medline Company Information Table 19. Medline Business Overview Table 20. Medline Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. Medline Hemostatic Forceps Product Portfolio Table 22. Medline Recent Developments Table 23. B. Braun Company Information Table 24. B. Braun Business Overview Table 25. B. Braun Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. B. Braun Hemostatic Forceps Product Portfolio Table 27. B. Braun Recent Developments Table 28. CareFusion Company Information Table 29. CareFusion Business Overview Table 30. CareFusion Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. CareFusion Hemostatic Forceps Product Portfolio Table 32. CareFusion Recent Developments Table 33. Asa Dental Company Information Table 34. Asa Dental Business Overview Table 35. Asa Dental Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. Asa Dental Hemostatic Forceps Product Portfolio Table 37. Asa Dental Recent Developments Table 38. Sklar Company Information Table 39. Sklar Business Overview Table 40. Sklar Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. Sklar Hemostatic Forceps Product Portfolio Table 42. Sklar Recent Developments Table 43. Scanlan International Company Information Table 44. Scanlan International Business Overview Table 45. Scanlan International Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Scanlan International Hemostatic Forceps Product Portfolio Table 47. Scanlan International Recent Developments Table 48. Shanghai Medical Instruments Company Information Table 49. Shanghai Medical Instruments Business Overview Table 50. Shanghai Medical Instruments Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. Shanghai Medical Instruments Hemostatic Forceps Product Portfolio Table 52. Shanghai Medical Instruments Recent Developments Table 53. Lawton Company Information Table 54. Lawton Business Overview Table 55. Lawton Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 56. Lawton Hemostatic Forceps Product Portfolio Table 57. Lawton Recent Developments Table 58. Hu-Friedy Company Information Table 59. Hu-Friedy Business Overview Table 60. Hu-Friedy Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Hu-Friedy Hemostatic Forceps Product Portfolio Table 62. Hu-Friedy Recent Developments Table 63. Xinhua Surgical Company Information Table 64. Xinhua Surgical Business Overview Table 65. Xinhua Surgical Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Xinhua Surgical Hemostatic Forceps Product Portfolio Table 67. Xinhua Surgical Recent Developments Table 68. Towne Brothers Company Information Table 69. Towne Brothers Business Overview Table 70. Towne Brothers Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Towne Brothers Hemostatic Forceps Product Portfolio Table 72. Towne Brothers Recent Developments Table 73. Teleflex Medical Company Information Table 74. Teleflex Medical Business Overview Table 75. Teleflex Medical Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Teleflex Medical Hemostatic Forceps Product Portfolio Table 77. Teleflex Medical Recent Developments Table 78. Delacroix Chevalier Company Information Table 79. Delacroix Chevalier Business Overview Table 80. Delacroix Chevalier Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Delacroix Chevalier Hemostatic Forceps Product Portfolio Table 82. Delacroix Chevalier Recent Developments Table 83. YDM Company Information Table 84. YDM Business Overview Table 85. YDM Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. YDM Hemostatic Forceps Product Portfolio Table 87. YDM Recent Developments Table 88. M A Corporation Company Information Table 89. M A Corporation Business Overview Table 90. M A Corporation Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. M A Corporation Hemostatic Forceps Product Portfolio Table 92. M A Corporation Recent Developments Table 93. MedGyn Products Company Information Table 94. MedGyn Products Business Overview Table 95. MedGyn Products Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. MedGyn Products Hemostatic Forceps Product Portfolio Table 97. MedGyn Products Recent Developments Table 98. Inami Company Information Table 99. Inami Business Overview Table 100. Inami Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Inami Hemostatic Forceps Product Portfolio Table 102. Inami Recent Developments Table 103. Ted Pella Company Information Table 104. Ted Pella Business Overview Table 105. Ted Pella Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Ted Pella Hemostatic Forceps Product Portfolio Table 107. Ted Pella Recent Developments Table 108. Medicon eG Company Information Table 109. Medicon eG Business Overview Table 110. Medicon eG Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Medicon eG Hemostatic Forceps Product Portfolio Table 112. Medicon eG Recent Developments Table 113. J & J Instruments Company Information Table 114. J & J Instruments Business Overview Table 115. J & J Instruments Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. J & J Instruments Hemostatic Forceps Product Portfolio Table 117. J & J Instruments Recent Developments Table 118. American Diagnostic Company Information Table 119. American Diagnostic Business Overview Table 120. American Diagnostic Hemostatic Forceps Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. American Diagnostic Hemostatic Forceps Product Portfolio Table 122. American Diagnostic Recent Developments Table 123. Global Hemostatic Forceps Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Hemostatic Forceps Sales by Region (2021-2026) & (K Units) Table 125. Global Hemostatic Forceps Sales Market Share by Region (2021-2026) Table 126. Global Hemostatic Forceps Sales by Region (2027-2032) & (K Units) Table 127. Global Hemostatic Forceps Sales Market Share by Region (2027-2032) Table 128. Global Hemostatic Forceps Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Hemostatic Forceps Revenue Market Share by Region (2021-2026) Table 130. Global Hemostatic Forceps Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Hemostatic Forceps Revenue Market Share by Region (2027-2032) Table 132. North America Hemostatic Forceps Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 134. North America Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 135. North America Hemostatic Forceps Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Hemostatic Forceps Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Hemostatic Forceps Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 139. Europe Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 140. Europe Hemostatic Forceps Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Hemostatic Forceps Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Hemostatic Forceps Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 144. Asia Pacific Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 145. Asia Pacific Hemostatic Forceps Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Hemostatic Forceps Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Hemostatic Forceps Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 149. South America Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 150. South America Hemostatic Forceps Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Hemostatic Forceps Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Hemostatic Forceps Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Hemostatic Forceps Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Hemostatic Forceps Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Hemostatic Forceps Sales by Type (2021-2026) & (K Units) Table 158. Global Hemostatic Forceps Sales by Type (2027-2032) & (K Units) Table 159. Global Hemostatic Forceps Sales Market Share by Type (2021-2026) Table 160. Global Hemostatic Forceps Sales Market Share by Type (2027-2032) Table 161. Global Hemostatic Forceps Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Hemostatic Forceps Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Hemostatic Forceps Revenue Market Share by Type (2021-2026) Table 164. Global Hemostatic Forceps Revenue Market Share by Type (2027-2032) Table 165. Global Hemostatic Forceps Price by Type (2021-2026) & (USD/Unit) Table 166. Global Hemostatic Forceps Price by Type (2027-2032) & (USD/Unit) Table 167. Global Hemostatic Forceps Sales by Application (2021-2026) & (K Units) Table 168. Global Hemostatic Forceps Sales by Application (2027-2032) & (K Units) Table 169. Global Hemostatic Forceps Sales Market Share by Application (2021-2026) Table 170. Global Hemostatic Forceps Sales Market Share by Application (2027-2032) Table 171. Global Hemostatic Forceps Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Hemostatic Forceps Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Hemostatic Forceps Revenue Market Share by Application (2021-2026) Table 174. Global Hemostatic Forceps Revenue Market Share by Application (2027-2032) Table 175. Global Hemostatic Forceps Price by Application (2021-2026) & (USD/Unit) Table 176. Global Hemostatic Forceps Price by Application (2027-2032) & (USD/Unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Hemostatic Forceps Distributors List Table 180. Hemostatic Forceps Customers List Table 181. Hemostatic Forceps Industry Trends Table 182. Hemostatic Forceps Industry Drivers Table 183. Hemostatic Forceps Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Hemostatic Forceps Product Image Figure 5. Global Hemostatic Forceps Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Hemostatic Forceps Market Size (2021-2032) & (US$ Million) Figure 7. Global Hemostatic Forceps Sales (2021-2032) & (K Units) Figure 8. Global Hemostatic Forceps Average Price (USD/Unit) & (2021-2032) Figure 9. Halstead Mosquito Hemostatic Forceps Product Image Figure 10. Kelly and Crile Hemostatic Forceps Product Image Figure 11. Rochester-Carmalt Hemostatic Forceps Product Image Figure 12. Surgical Product Image Figure 13. Dissection Product Image Figure 14. Dental Product Image Figure 15. Laparoscopic Product Image Figure 16. Others Product Image Figure 17. Global Hemostatic Forceps Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Hemostatic Forceps, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Hemostatic Forceps Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Hemostatic Forceps Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Hemostatic Forceps Sales by Region in 2025 Figure 23. Global Hemostatic Forceps Revenue by Region in 2025 Figure 24. North America Hemostatic Forceps Market Size by Country in 2025 Figure 25. North America Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 26. North America Hemostatic Forceps Revenue Market Share by Country (2021-2032) Figure 27. United States Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Hemostatic Forceps Market Size by Country in 2025 Figure 31. Europe Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 32. Europe Hemostatic Forceps Revenue Market Share by Country (2021-2032) Figure 33. Germany Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Hemostatic Forceps Market Size by Country in 2025 Figure 44. Asia Pacific Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Hemostatic Forceps Revenue Market Share by Country (2021-2032) Figure 46. China Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Hemostatic Forceps Market Size by Country in 2025 Figure 55. South America Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 56. South America Hemostatic Forceps Revenue Market Share by Country (2021-2032) Figure 57. Brazil Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Hemostatic Forceps Market Size by Country in 2025 Figure 61. Middle East and Africa Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Hemostatic Forceps Revenue Market Share by Country (2021-2032) Figure 63. Egypt Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Hemostatic Forceps Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Hemostatic Forceps Sales Market Share by Type (2021-2032) Figure 69. Global Hemostatic Forceps Revenue Market Share by Type (2021-2032) Figure 70. Global Hemostatic Forceps Price (USD/Unit) by Type (2021-2032) Figure 71. Global Hemostatic Forceps Sales Market Share by Application (2021-2032) Figure 72. Global Hemostatic Forceps Revenue Market Share by Application (2021-2032) Figure 73. Global Hemostatic Forceps Price (USD/Unit) by Application (2021-2032) Figure 74. Hemostatic Forceps Value Chain Figure 75. Hemostatic Forceps Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Hemostatic Forceps Industry Opportunities and Challenges

Scope & coverage.

Types
  • Halstead Mosquito Hemostatic Forceps
  • Kelly and Crile Hemostatic Forceps
  • Rochester-Carmalt Hemostatic Forceps
Applications
  • Surgical
  • Dissection
  • Dental
  • Laparoscopic
  • Others
Companies covered
  • Medline
  • B. Braun
  • CareFusion
  • Asa Dental
  • Sklar
  • Scanlan International
  • Shanghai Medical Instruments
  • Lawton
  • Hu-Friedy
  • Xinhua Surgical
  • Towne Brothers
  • Teleflex Medical
  • Delacroix Chevalier
  • YDM
  • M A Corporation
  • MedGyn Products
  • Inami
  • Ted Pella
  • Medicon eG
  • J & J Instruments
  • American Diagnostic

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Hemostatic Forceps Market Size (2021-2032)
  4. 2.2.2 Global Hemostatic Forceps Sales (2021-2032)
  5. 2.2.3 Global Hemostatic Forceps Market Average Price (2021-2032)
  6. 2.3 Hemostatic Forceps by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Halstead Mosquito Hemostatic Forceps
  9. 2.3.3 Kelly and Crile Hemostatic Forceps
  10. 2.3.4 Rochester-Carmalt Hemostatic Forceps
  11. 2.4 Hemostatic Forceps by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Surgical
  14. 2.4.3 Dissection
  15. 2.4.4 Dental
  16. 2.4.5 Laparoscopic
  17. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Hemostatic Forceps Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Hemostatic Forceps Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Hemostatic Forceps Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Hemostatic Forceps Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Hemostatic Forceps Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Hemostatic Forceps, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Hemostatic Forceps, Product Type & Application
  8. 3.8 Global Manufacturers of Hemostatic Forceps, Established Date
  9. 3.9 Global Hemostatic Forceps Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Medline
  2. 4.1.1 Medline Company Information
  3. 4.1.2 Medline Business Overview
  4. 4.1.3 Medline Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Medline Hemostatic Forceps Product Portfolio
  6. 4.1.5 Medline Recent Developments
  7. 4.2 B. Braun
  8. 4.2.1 B. Braun Company Information
  9. 4.2.2 B. Braun Business Overview
  10. 4.2.3 B. Braun Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 B. Braun Hemostatic Forceps Product Portfolio
  12. 4.2.5 B. Braun Recent Developments
  13. 4.3 CareFusion
  14. 4.3.1 CareFusion Company Information
  15. 4.3.2 CareFusion Business Overview
  16. 4.3.3 CareFusion Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CareFusion Hemostatic Forceps Product Portfolio
  18. 4.3.5 CareFusion Recent Developments
  19. 4.4 Asa Dental
  20. 4.4.1 Asa Dental Company Information
  21. 4.4.2 Asa Dental Business Overview
  22. 4.4.3 Asa Dental Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Asa Dental Hemostatic Forceps Product Portfolio
  24. 4.4.5 Asa Dental Recent Developments
  25. 4.5 Sklar
  26. 4.5.1 Sklar Company Information
  27. 4.5.2 Sklar Business Overview
  28. 4.5.3 Sklar Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sklar Hemostatic Forceps Product Portfolio
  30. 4.5.5 Sklar Recent Developments
  31. 4.6 Scanlan International
  32. 4.6.1 Scanlan International Company Information
  33. 4.6.2 Scanlan International Business Overview
  34. 4.6.3 Scanlan International Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Scanlan International Hemostatic Forceps Product Portfolio
  36. 4.6.5 Scanlan International Recent Developments
  37. 4.7 Shanghai Medical Instruments
  38. 4.7.1 Shanghai Medical Instruments Company Information
  39. 4.7.2 Shanghai Medical Instruments Business Overview
  40. 4.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shanghai Medical Instruments Hemostatic Forceps Product Portfolio
  42. 4.7.5 Shanghai Medical Instruments Recent Developments
  43. 4.8 Lawton
  44. 4.8.1 Lawton Company Information
  45. 4.8.2 Lawton Business Overview
  46. 4.8.3 Lawton Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Lawton Hemostatic Forceps Product Portfolio
  48. 4.8.5 Lawton Recent Developments
  49. 4.9 Hu-Friedy
  50. 4.9.1 Hu-Friedy Company Information
  51. 4.9.2 Hu-Friedy Business Overview
  52. 4.9.3 Hu-Friedy Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hu-Friedy Hemostatic Forceps Product Portfolio
  54. 4.9.5 Hu-Friedy Recent Developments
  55. 4.10 Xinhua Surgical
  56. 4.10.1 Xinhua Surgical Company Information
  57. 4.10.2 Xinhua Surgical Business Overview
  58. 4.10.3 Xinhua Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Xinhua Surgical Hemostatic Forceps Product Portfolio
  60. 4.10.5 Xinhua Surgical Recent Developments
  61. 4.11 Towne Brothers
  62. 4.11.1 Towne Brothers Company Information
  63. 4.11.2 Towne Brothers Business Overview
  64. 4.11.3 Towne Brothers Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Towne Brothers Hemostatic Forceps Product Portfolio
  66. 4.11.5 Towne Brothers Recent Developments
  67. 4.12 Teleflex Medical
  68. 4.12.1 Teleflex Medical Company Information
  69. 4.12.2 Teleflex Medical Business Overview
  70. 4.12.3 Teleflex Medical Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Teleflex Medical Hemostatic Forceps Product Portfolio
  72. 4.12.5 Teleflex Medical Recent Developments
  73. 4.13 Delacroix Chevalier
  74. 4.13.1 Delacroix Chevalier Company Information
  75. 4.13.2 Delacroix Chevalier Business Overview
  76. 4.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Delacroix Chevalier Hemostatic Forceps Product Portfolio
  78. 4.13.5 Delacroix Chevalier Recent Developments
  79. 4.14 YDM
  80. 4.14.1 YDM Company Information
  81. 4.14.2 YDM Business Overview
  82. 4.14.3 YDM Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 YDM Hemostatic Forceps Product Portfolio
  84. 4.14.5 YDM Recent Developments
  85. 4.15 M A Corporation
  86. 4.15.1 M A Corporation Company Information
  87. 4.15.2 M A Corporation Business Overview
  88. 4.15.3 M A Corporation Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 M A Corporation Hemostatic Forceps Product Portfolio
  90. 4.15.5 M A Corporation Recent Developments
  91. 4.16 MedGyn Products
  92. 4.16.1 MedGyn Products Company Information
  93. 4.16.2 MedGyn Products Business Overview
  94. 4.16.3 MedGyn Products Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 MedGyn Products Hemostatic Forceps Product Portfolio
  96. 4.16.5 MedGyn Products Recent Developments
  97. 4.17 Inami
  98. 4.17.1 Inami Company Information
  99. 4.17.2 Inami Business Overview
  100. 4.17.3 Inami Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Inami Hemostatic Forceps Product Portfolio
  102. 4.17.5 Inami Recent Developments
  103. 4.18 Ted Pella
  104. 4.18.1 Ted Pella Company Information
  105. 4.18.2 Ted Pella Business Overview
  106. 4.18.3 Ted Pella Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Ted Pella Hemostatic Forceps Product Portfolio
  108. 4.18.5 Ted Pella Recent Developments
  109. 4.19 Medicon eG
  110. 4.19.1 Medicon eG Company Information
  111. 4.19.2 Medicon eG Business Overview
  112. 4.19.3 Medicon eG Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Medicon eG Hemostatic Forceps Product Portfolio
  114. 4.19.5 Medicon eG Recent Developments
  115. 4.20 J & J Instruments
  116. 4.20.1 J & J Instruments Company Information
  117. 4.20.2 J & J Instruments Business Overview
  118. 4.20.3 J & J Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 J & J Instruments Hemostatic Forceps Product Portfolio
  120. 4.20.5 J & J Instruments Recent Developments
  121. 4.21 American Diagnostic
  122. 4.21.1 American Diagnostic Company Information
  123. 4.21.2 American Diagnostic Business Overview
  124. 4.21.3 American Diagnostic Hemostatic Forceps Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 American Diagnostic Hemostatic Forceps Product Portfolio
  126. 4.21.5 American Diagnostic Recent Developments
5 Global Hemostatic Forceps Market Scenario by Region
  1. 5.1 Global Hemostatic Forceps Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Hemostatic Forceps Sales by Region: 2021-2032
  3. 5.2.1 Global Hemostatic Forceps Sales by Region: 2021-2026
  4. 5.2.2 Global Hemostatic Forceps Sales by Region: 2027-2032
  5. 5.3 Global Hemostatic Forceps Revenue by Region: 2021-2032
  6. 5.3.1 Global Hemostatic Forceps Revenue by Region: 2021-2026
  7. 5.3.2 Global Hemostatic Forceps Revenue by Region: 2027-2032
  8. 5.4 North America Hemostatic Forceps Market Facts & Figures by Country
  9. 5.4.1 North America Hemostatic Forceps Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Hemostatic Forceps Sales by Country (2021-2032)
  11. 5.4.3 North America Hemostatic Forceps Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Hemostatic Forceps Market Facts & Figures by Country
  16. 5.5.1 Europe Hemostatic Forceps Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Hemostatic Forceps Sales by Country (2021-2032)
  18. 5.5.3 Europe Hemostatic Forceps Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Hemostatic Forceps Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Hemostatic Forceps Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Hemostatic Forceps Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Hemostatic Forceps Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Hemostatic Forceps Market Facts & Figures by Country
  41. 5.7.1 South America Hemostatic Forceps Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Hemostatic Forceps Sales by Country (2021-2032)
  43. 5.7.3 South America Hemostatic Forceps Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Hemostatic Forceps Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Hemostatic Forceps Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Hemostatic Forceps Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Hemostatic Forceps Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Hemostatic Forceps Sales by Type (2021-2032)
  2. 6.1.1 Global Hemostatic Forceps Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Hemostatic Forceps Sales Market Share by Type (2021-2032)
  4. 6.2 Global Hemostatic Forceps Revenue by Type (2021-2032)
  5. 6.2.1 Global Hemostatic Forceps Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Hemostatic Forceps Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Hemostatic Forceps Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Hemostatic Forceps Sales by Application (2021-2032)
  2. 7.1.1 Global Hemostatic Forceps Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Hemostatic Forceps Sales Market Share by Application (2021-2032)
  4. 7.2 Global Hemostatic Forceps Revenue by Application (2021-2032)
  5. 7.2.1 Global Hemostatic Forceps Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Hemostatic Forceps Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Hemostatic Forceps Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Hemostatic Forceps Value Chain Analysis
  2. 8.1.1 Hemostatic Forceps Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Hemostatic Forceps Production Mode & Process
  5. 8.2 Hemostatic Forceps Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Hemostatic Forceps Distributors
  8. 8.2.3 Hemostatic Forceps Customers
9 Global Hemostatic Forceps Analyzing Market Dynamics
  1. 9.1 Hemostatic Forceps Industry Trends
  2. 9.2 Hemostatic Forceps Industry Drivers
  3. 9.3 Hemostatic Forceps Industry Opportunities and Challenges
  4. 9.4 Hemostatic Forceps Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research